Results 91 to 100 of about 66,662 (177)

Imatinib Mesylate and Sirolimus Inhibit Vascular Fibroproliferative Remodeling in Pulmonary Vein Stenosis. [PDF]

Children (Basel)
Gaal J, Doettl SC, Saraci K, Zajac C, von Mueffling A, Hammer PE, von Piechowski M, Gebert V, Caracioni AM, Diaz-Gil D, Weixler V, Del Nido PJ, Jenkins K, Friehs I.   +13 more
europepmc   +1 more source

Short-Term Efficacy and Safety of Topical Sirolimus Gel in Pediatric Superficial Microcystic Lymphatic Malformations: A Single-Center Interventional Study of 30 Patients. [PDF]

Vasc Health Risk Manag
Xu W, Ding Y, Zhao L, Pi M, Zhang X, Xu M, Ma K.   +6 more
europepmc   +1 more source

Topical Sirolimus Gel for the Treatment of Superficial Microcystic Lymphatic Malformations in Pediatric Patients: A Case Series. [PDF]

Clin Cosmet Investig Dermatol
Cui X, Tang L, Ma K, Qian Q.
europepmc   +1 more source

Sirolimus for refractory/relapsed warm autoimmune hemolytic anemia and Evans syndrome: a prospective study. [PDF]

Blood Adv
Wang Q, Liu Z, Yang C, Li J, Chen M, Han B.   +5 more
europepmc   +1 more source

Favorable response to second-line sirolimus regardless of <i>STAT3/5b</i> status in acquired pure red cell aplasia: A retrospective study from a single center. [PDF]

Ther Adv Hematol
Sun Z, Jia X, Shen Y, Yang X, Liu Q, Ge H, Zhang Y, Zheng Z, Shen Y, Zhou Y, Wu D.   +10 more
europepmc   +1 more source

Transcatheter embolization as a rescue therapy for refractory pelvic kaposiform hemangioendothelioma with Kasabachi-Merritt phenomenon: a case report. [PDF]

Front Pediatr
Xiong Y, Di Q, Li S, Cao J, Chen C, Shen G.   +5 more
europepmc   +1 more source

Maternal Sirolimus Therapy for Fetal Extensive Lymphatic Cystic Malformation: Selection Criteria, Management, and Outcomes in a Series of Six Cases. [PDF]

Prenat Diagn
Guibaud L, Bordas-Fournel M, Cabet S, Le Vaillant C, Bruel A, Lefrançois T, Megier C, Benachi A, Sohier M, Gallois Y, Simon T, Jouannic JM, Canaud G, Guilhem A, Atallah A, Fraissenon A.   +15 more
europepmc   +1 more source

Sirolimus application in patients with autoimmune-associated kidney diseases based on mTORC1 activation: a preliminary exploration and future perspectives. [PDF]

Front Pharmacol
Sun C, Wan L, Gao H, Ding Y, Qu Z, Yu F.
europepmc   +1 more source

Topical sirolimus for the treatment of verrucous epidermal nevus associated with an <i>HRAS</i> mosaic mutation: a case report. [PDF]

Front Med (Lausanne)
Wei QJ, Xiang WY, Zheng WJ, Li QJ.
europepmc   +1 more source

Case Report: Activated phosphoinositide 3-kinase δ syndrome mimicking Hyper-IgM syndrome: early hepatosplenomegaly as a key diagnostic clue. [PDF]

Front Immunol
Nguyen ATV, Nguyen GD, Bui QTT, Nguyen MTP, Ha AP, Chu HH, Dang HT, Hoàng CP, Nguyen VD, Cao TV, Tran DM.   +10 more
europepmc   +1 more source